Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:933-936

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, N.
Right arrow Articles by Yazaki, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, N.
Right arrow Articles by Yazaki, Y.
Related Collections
Right arrow Other hypertension

(Hypertension. 1999;33:933-936.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Lack of Evidence for Association Between the Endothelial Nitric Oxide Synthase Gene and Hypertension

Norihiro Kato; Takao Sugiyama; Hiroyuki Morita; Toru Nabika; Hiroki Kurihara; Yukio Yamori; Yoshio Yazaki

From the Graduate School of Human and Environmental Studies, University of Kyoto (N.K., Y.Y.); The Institute for Adult Diseases Asahi Life Foundation, Tokyo (T.S.); the Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo (H.M., H.K., Y.Y.); and the Department of Laboratory Medicine, Shimane Medical University (T.N.).

Correspondence to Norihiro Kato, MD, PhD, Graduate School of Human and Environmental Studies, University of Kyoto, Yoshida Nihonmatsu-cho Sakyo-ku, Kyoto 606, Japan. E-mail kato{at}helios.jinkan.kyoto-u.ac.jp

Abstract—Significant association between a Glu298Asp polymorphism of the endothelial nitric oxide synthase (eNOS) gene and essential hypertension was recently reported in Japanese populations, with the 298Asp variant showing a higher prevalence in hypertensive patients (10.3% to 12.0%) than in normotensive subjects (5.0% to 5.8%). In contrast, another study demonstrated that the 298Glu variant was significantly associated with hypertension in a Caucasian population. We therefore undertook an extensive association study in Japanese to resolve these contradictory claims. A total of 1165 individuals were selected from clinic outpatients and hospital staff in a single institution. The relevance of the Glu298Asp polymorphism to hypertension in this population was tested in 2 ways. First, a case-control study was conducted in 549 hypertensive and 513 normotensive subjects within the study population, with the {chi}2 statistic used to test the significance of an association between eNOS genotype and the presence of hypertension. Second, an ANOVA was used to test the significance of an association between eNOS genotype and the level of blood pressure within the entire population except for 167 hypertensive subjects who had been under treatment for hypertension. No significant association was observed in either of the statistics tested. Allele frequencies of 298Asp were concordant across the panels: 8.4% in hypertensive subjects, 8.2% in normotensive subjects, and 7.9% and 9.5% in 2 additional sample populations used as reference panels. Taken together, our results do not support the previous observation that the molecular variant of the eNOS gene may confer principal susceptibility for essential hypertension but rather suggest the existence of sampling variation.


Key Words: hypertension, essential • Japanese • genetics • nitric oxide synthase




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
C. X. Zhao, X. Xu, Y. Cui, P. Wang, X. Wei, S. Yang, M. L. Edin, D. C. Zeldin, and D. W. Wang
Increased Endothelial Nitric-Oxide Synthase Expression Reduces Hypertension and Hyperinsulinemia in Fructose-Treated Rats
J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 610 - 620.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. F. Mitchell, C.-Y. Guo, S. Kathiresan, R. S. Vasan, M. G. Larson, J. A. Vita, M. J. Keyes, M. Vyas, C. Newton-Cheh, S. L. Musone, et al.
Vascular Stiffness and Genetic Variation at the Endothelial Nitric Oxide Synthase Locus: The Framingham Heart Study
Hypertension, June 1, 2007; 49(6): 1285 - 1290.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. L. Gonzalez-Sanchez, M. T. Martinez-Larrad, M. E. Saez, C. Zabena, M. J. Martinez-Calatrava, and M. Serrano-Rios
Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome
Clin. Chem., January 1, 2007; 53(1): 91 - 97.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. P. Casas, G. L. Cavalleri, L. E. Bautista, L. Smeeth, S. E. Humphries, and A. D. Hingorani
Endothelial Nitric Oxide Synthase Gene Polymorphisms and Cardiovascular Disease: A HuGE Review
Am. J. Epidemiol., November 15, 2006; 164(10): 921 - 935.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Zintzaras, G. Kitsios, and I. Stefanidis
Endothelial NO Synthase Gene Polymorphisms and Hypertension: A Meta-Analysis
Hypertension, October 1, 2006; 48(4): 700 - 710.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Malhotra, J. Poole, H. Davis, Y. Dong, J. Pollock, H. Snieder, and F. Treiber
Effects of NOS3 Glu298Asp Polymorphism on Hemodynamic Reactivity to Stress: Influences of Ethnicity and Obesity
Hypertension, December 1, 2004; 44(6): 866 - 871.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. Chen, S. R. Srinivasan, S. Li, E. Boerwinkle, and G. S. Berenson
Gender-Specific Influence of NO Synthase Gene on Blood Pressure Since Childhood: The Bogalusa Heart Study
Hypertension, November 1, 2004; 44(5): 668 - 673.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
M. A Schmidt, A. K Chakrabarti, C. Kehrer, D. Pfeninnger, R. D Brook, N. Kaciroti, C. Duvernoy, A. A Killeen, and S. Rajagopalan
Interactive effects of the ACE DD polymorphism with the NOS III homozygous G849T (Glu298->Asp) variant in determining endothelial function in coronary artery disease
Vascular Medicine, August 1, 2003; 8(3): 177 - 183.
[Abstract] [PDF]


Home page
HypertensionHome page
T. Kimura, T. Yokoyama, Y. Matsumura, N. Yoshiike, C. Date, M. Muramatsu, and H. Tanaka
NOS3 Genotype-Dependent Correlation Between Blood Pressure and Physical Activity
Hypertension, February 1, 2003; 41(2): 355 - 360.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Rankinen, T. Rice, L. Perusse, Y. C. Chagnon, J. Gagnon, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, and C. Bouchard
NOS3 Glu298Asp Genotype and Blood Pressure Response to Endurance Training : The HERITAGE Family Study
Hypertension, November 1, 2000; 36(5): 885 - 889.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Busse and I. Fleming
A critical look at cardiovascular translational research
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1655 - H1660.
[Full Text] [PDF]


Home page
HypertensionHome page
F. Soubrier
Nitric Oxide Synthase Genes : Candidate Genes Among Many Others
Hypertension, April 1, 1999; 33(4): 924 - 926.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Fairchild, D. Fulton, J. T. Fontana, J.-P. Gratton, T. J. McCabe, and W. C. Sessa
Acidic Hydrolysis as a Mechanism for the Cleavage of the Glu298right-arrow Asp Variant of Human Endothelial Nitric-oxide Synthase
J. Biol. Chem., July 6, 2001; 276(28): 26674 - 26679.
[Abstract] [Full Text] [PDF]